Effects of long-term treatment of alogliptin on glycemic control in Japanese patients with type 2 diabetes

Effects of long-term treatment of alogliptin on glycemic control in Japanese patients with type 2 diabetes - Effects of long-term treatment of alogliptin on glycemic control in Japanese patients with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015268

Enrollment

Registered

2014-09-27

Start date

2013-06-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Alogliptin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes patients. Obtained written informed consent from the patients before participation. Treated with sitagliptin for >1 year before participation.

Exclusion criteria

Exclusion criteria: Complicated severe nephropathy.

Design outcomes

Primary

Measure	Time frame
Blood Hemoglobin A1c level	—

Secondary

Measure	Time frame
Casual blood glucose and serum total cholestrol, HDL cholestrol, LDL cholestrol, and triglyceirde levels	—

Countries

Japan

Contacts

Public ContactMasataka Kusunoki

Aichi Medical University Department of Internal Medicine, Medical Clinic

info@tonyo.jp052-931-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026